Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26F9M10
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,769
Award facts
- Contract value 100% obligated
- $48,769.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $48,769.00 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a completion date of December 5, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates significant capability as a federal medical vendor through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies critical medical commodities including specialty medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This award for continuous glucose monitoring devices reflects AmerisourceBergen's role in providing essential diabetes management solutions as part of the broader military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F9M10?
SPE2DR26F9M10 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F9M10 worth?
The government has obligated $48,769 on SPE2DR26F9M10.
Is contract SPE2DR26F9M10 an order under another contract?
Yes. SPE2DR26F9M10 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9M10 competed?
The extent of competition for SPE2DR26F9M10 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award